Published in Res Vet Sci on December 17, 1997
Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2. J Virol (2007) 1.70
Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection. Immunol Cell Biol (2009) 1.02
Papillomavirus prophylactic vaccines: established successes, new approaches. J Virol (2009) 1.00
A multimeric L2 vaccine for prevention of animal papillomavirus infections. Virology (2011) 0.76
Conservation of cytoplasmic poly (A)-containing RNA in mouse and rat. Nature (1975) 2.18
Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology (1996) 2.08
Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol (1993) 1.99
Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. Virology (1991) 1.70
Transcriptional control signals in the genome of bovine papillomavirus type 1. Nature (1983) 1.70
Repetitive DNA sequences near three human beta-type globin genes. Nucleic Acids Res (1980) 1.55
Negative regulation of the human epsilon-globin gene by transcriptional interference: role of an Alu repetitive element. Mol Cell Biol (1990) 1.51
Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4. Virology (1995) 1.48
Epsilon globin gene transcripts originating upstream of the mRNA cap site in K562 cells and normal human embryos. Nucleic Acids Res (1982) 1.47
Persistence of non-integrated viral DNA in bovine cells transformed in vitro by bovine papillomavirus type 2. Nature (1981) 1.35
Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies. J Gen Virol (1996) 1.32
Prophylactic and therapeutic vaccination against a mucosal papillomavirus. J Gen Virol (1993) 1.26
Apoptosis, proliferation, and angiogenesis in oral tissues. Possible relevance to tumour progression. J Pathol (2000) 1.25
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol (1995) 1.25
Tandem integration of complete and defective SV40 genomes in mouse-human somatic cell hybrids. Cell (1978) 1.24
A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease. Virology (1997) 1.22
Alternative sites of transcription initiation upstream of the canonical cap site in human gamma-globin and beta-globin genes. Nucleic Acids Res (1984) 1.20
Two classes of messenger RNA in cultured rat cells: repetitive sequence transcripts and unique sequence transcripts. J Mol Biol (1974) 1.16
Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination. Vet Rec (1990) 1.15
Unintegrated viral DNA sequences in a hamster tumor induced by bovine papilloma virus. J Virol (1981) 1.14
Molecular heterogeneity and lesion site specificity of cutaneous bovine papillomaviruses. Virology (1981) 1.13
Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types. Vet Rec (1990) 1.11
Virus-induced papillomas of the alimentary tract of cattle. Int J Cancer (1978) 1.11
Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle. Carcinogenesis (1994) 1.09
alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4. J Gen Virol (2000) 1.09
Association of bovine papillomavirus with the equine sarcoid. J Gen Virol (2003) 1.07
The B subgroup bovine papillomaviruses lack an identifiable E6 open reading frame. Mol Carcinog (1991) 1.06
Association of bovine papillomavirus type 2 and bracken fern with bladder cancer in cattle. Cancer Res (1992) 1.06
Multiple interactions between cellular factors and the non-coding region of human papillomavirus type 16. J Gen Virol (1990) 1.01
DNA-RNA hybridization. Philos Trans R Soc Lond B Biol Sci (1975) 0.99
The nucleotide sequence and genome organization of bovine papillomavirus type 4. J Gen Virol (1987) 0.99
Molecular cloning and characterization of human papillomavirus type 7 DNA. Virology (1986) 0.98
A novel bovine papillomavirus (BPV-6) causing true epithelial papillomas of the mammary gland skin: a member of a proposed new BPV subgroup. Virology (1984) 0.98
Down-regulation of MHC class I is a property common to papillomavirus E5 proteins. Virus Res (2006) 0.98
Assessment of vascularity in histological sections: effects of methodology and value as an index of angiogenesis in breast tumours. Histochem J (1998) 0.97
Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor beta receptor in naturally occurring bovine urinary bladder tumours. Oncogene (2006) 0.96
Tissue specific transcription of the human epsilon-globin gene following transfection into the embryonic erythroid cell line K562. Nucleic Acids Res (1985) 0.96
The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts. J Virol (1996) 0.95
Repetitious and unique sequences in the heterogeneous nuclear and cytoplasmic messenger RNA of mammalian and insect cells. Cell (1974) 0.92
Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region. J Virol (1995) 0.92
Role of different sponge cell types in species specific cell aggregation. Nat New Biol (1971) 0.91
Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids. Virology (2008) 0.89
DNA sequences of human papillomavirus types 11, 16, and 18 in lesions of the uterine cervix in the west of Scotland. Br Med J (Clin Res Ed) (1986) 0.87
The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1. J Virol (1995) 0.87
Molecularly cloned bovine papillomavirus DNA transforms mouse fibroblasts in vitro. J Gen Virol (1983) 0.86
Human papillomavirus DNA in biopsies of oral tissues. J Gen Virol (1991) 0.86
The biology of papillomaviruses and their role in oncogenesis. Anticancer Res (1985) 0.86
Biosynthesis and distribution of ribosomal particles in the cellular slime mould, Dictyostelium purpureum. J Mol Biol (1970) 0.85
Positive and negative E2-independent regulatory elements in the long control region of bovine papillomavirus type 4. J Gen Virol (1991) 0.85
Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Res (2003) 0.85
E5 transforming proteins of papillomaviruses do not disturb the activity of the vacuolar H(+)-ATPase. J Gen Virol (2001) 0.85
Heterogeneity in microvascular density in lung tumours: comparison with normal bronchus. Br J Cancer (1998) 0.85
Phenotypical characterization of lymphocytes infiltrating regressing papillomas. J Virol (1996) 0.85
Molecular cloning of bovine papillomavirus genomes and comparison of their sequence homologies by heteroduplex mapping. J Gen Virol (1982) 0.84
Characterization of a nuclear factor, papilloma enhancer binding factor-1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity. Mol Carcinog (1993) 0.84
Presence of beta human papillomaviruses in nonmelanoma skin cancer from organ transplant recipients and immunocompetent patients in the West of Scotland. Br J Dermatol (2009) 0.84
Analysis of the transforming functions of bovine papillomavirus type 4. Virology (1993) 0.83
A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein. J Virol (2001) 0.83
Extensive papillomatosis of the bovine upper gastrointestinal tract. J Comp Pathol (2003) 0.82
Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1. J Gen Virol (2008) 0.82
A new transmissible agent causing acute hepatitis, chronic hepatitis and cirrhosis in dogs. Vet Rec (1985) 0.82
Immunoglobulin genes expressed by B-lymphocytes infiltrating cervical carcinomas show evidence of antigen-driven selection. Cancer Immunol Immunother (2001) 0.82
Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2. Virus Res (2005) 0.82
Cooperation between bovine papillomavirus type 4 and ras in the morphological transformation of primary bovine fibroblasts. J Gen Virol (1990) 0.82
Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts. J Virol (2008) 0.81
An enhanced epithelial response of a papillomavirus promoter to transcriptional activators. J Biol Chem (1999) 0.81
Bovine papillomavirus type 1 DNA and E5 oncoprotein expression in water buffalo fibropapillomas. Vet Pathol (2009) 0.81
Ribosomal subunits in Dictyostelium discoideum. The effect of an ionic detergent and a nonionic detergent. Biochim Biophys Acta (1969) 0.81
Bovine papillomavirus type 4 in oesophageal papillomas of cattle from the south of Italy. J Comp Pathol (2003) 0.81
Cooperation between papillomavirus and chemical cofactors in oncogenesis. Crit Rev Oncog (1993) 0.80
Multiple Harvey-ras genes in the bovine genome. Oncogene (1989) 0.80
High levels of apoptosis are associated with improved survival in non-small cell lung cancer. Anticancer Res (2000) 0.80
Papillomavirus infection in cattle: viral and chemical cofactors in naturally occurring and experimentally induced tumours. Ciba Found Symp (1986) 0.80
Mapping of two novel transcripts of bovine papillomavirus type 4. J Gen Virol (1988) 0.79
Generation of native bovine mAbs by phage display. Proc Natl Acad Sci U S A (1999) 0.79
Malignant transformation of a papilloma induced by bovine papillomavirus type 4 in the nude mouse renal capsule. J Gen Virol (1991) 0.79
T cell responses to BPV-4 E7 during infection and mapping of T cell epitopes. Virology (1995) 0.79